DD216005A5 - Verfahren zur herstellung von pyrrolidinonderivaten - Google Patents

Verfahren zur herstellung von pyrrolidinonderivaten Download PDF

Info

Publication number
DD216005A5
DD216005A5 DD84259606A DD25960684A DD216005A5 DD 216005 A5 DD216005 A5 DD 216005A5 DD 84259606 A DD84259606 A DD 84259606A DD 25960684 A DD25960684 A DD 25960684A DD 216005 A5 DD216005 A5 DD 216005A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
hydrogen
acid
salt
Prior art date
Application number
DD84259606A
Other languages
German (de)
English (en)
Inventor
William Bencze
Bruno Kamber
Angelo Storni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD216005A5 publication Critical patent/DD216005A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD84259606A 1983-01-27 1984-01-25 Verfahren zur herstellung von pyrrolidinonderivaten DD216005A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH45383 1983-01-27

Publications (1)

Publication Number Publication Date
DD216005A5 true DD216005A5 (de) 1984-11-28

Family

ID=4187370

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84259606A DD216005A5 (de) 1983-01-27 1984-01-25 Verfahren zur herstellung von pyrrolidinonderivaten

Country Status (12)

Country Link
EP (1) EP0115472A3 (enrdf_load_html_response)
JP (1) JPS59141559A (enrdf_load_html_response)
KR (1) KR840007571A (enrdf_load_html_response)
AU (1) AU2383884A (enrdf_load_html_response)
DD (1) DD216005A5 (enrdf_load_html_response)
DK (1) DK35884A (enrdf_load_html_response)
FI (1) FI840260L (enrdf_load_html_response)
GR (1) GR81746B (enrdf_load_html_response)
IL (1) IL70772A0 (enrdf_load_html_response)
NO (1) NO840310L (enrdf_load_html_response)
PT (1) PT78007B (enrdf_load_html_response)
ZA (1) ZA84560B (enrdf_load_html_response)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943625C (de) * 1943-06-28 1956-05-24 Ferguson Harry Inc Seitensteuerungseinrichtung fuer ein landwirtschaftliches Schlepperanbaugeraet
JPH0696574B2 (ja) * 1987-09-16 1994-11-30 三菱化成株式会社 ４−ピペリジンカルボキサミド誘導体
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
JP2997488B2 (ja) * 1989-12-25 2000-01-11 興研株式会社 腫瘍細胞増殖抑制剤
CA2172125A1 (en) * 1993-09-30 1995-04-06 S. Jane Desolms Inhibitors of farnesyl-protein transferase
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
TW201206425A (en) 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
JP5323481B2 (ja) 2005-07-29 2013-10-23 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート 長期記憶を増強するための、ｐｋｃ賦活薬の単独またはｐｋｃ阻害剤と組み合わせての使用
EP2121000B1 (en) 2007-02-09 2015-09-23 Blanchette Rockefeller Neurosciences, Institute Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins
GB1539817A (en) * 1976-10-22 1979-02-07 Ucb Sa N-substituted lactams

Also Published As

Publication number Publication date
JPS59141559A (ja) 1984-08-14
FI840260A7 (fi) 1984-07-28
ZA84560B (en) 1984-09-26
FI840260L (fi) 1984-07-28
PT78007B (en) 1986-06-18
EP0115472A3 (de) 1985-10-02
PT78007A (en) 1984-02-01
AU2383884A (en) 1984-08-02
KR840007571A (ko) 1984-12-08
DK35884A (da) 1984-07-28
IL70772A0 (en) 1984-04-30
GR81746B (enrdf_load_html_response) 1984-12-12
NO840310L (no) 1984-07-30
DK35884D0 (da) 1984-01-26
FI840260A0 (fi) 1984-01-23
EP0115472A2 (de) 1984-08-08

Similar Documents

Publication Publication Date Title
EP0119161B1 (de) Gewisse Benzazocinon- und Benzazoninon-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
EP0197478B1 (de) Neue Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0548024B1 (de) Aminosulfonsäurederivate und Verfahren zu ihrer Herstellung
EP0111266A2 (de) Substituierte Tetrapeptide
DD236522A5 (de) Verfahren zur herstellung medizinisch wertvoller verbindungen und zwischenverbindungen
DD216005A5 (de) Verfahren zur herstellung von pyrrolidinonderivaten
DD247680A5 (de) Verfahren zur herstellung von phosphatidylverbindungen
EP0495750A2 (de) Heterozyklische Hydroxylamine
EP0374095A2 (de) Piperidinderivate
DD283807A5 (de) Verfahren zur herstellung von cycloalkyl-substituierten glutaramid-derivaten
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
EP0099578A1 (de) Neue Muramylpeptide und Verfahren zu ihrer Herstellung
EP0233837A2 (de) Saccharidderivate und Verfahren zu ihrer Herstellung
DE69115135T2 (de) 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
DE2112057A1 (de) Neue Penicillinester
DE69633557T2 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
EP0115473A2 (de) Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
DE3825242A1 (de) Durch schwefelhaltige gruppen substituierte histidinylamino-verbindungen
DE69019217T2 (de) Perylenquinon (UCN-1028D)-Derivate.
DE19581497B4 (de) Neue Derivate des Tetramethylcyclopropans
EP0174912A2 (de) Phosphorverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69018816T2 (de) Aminosäurederivate.
DD202144A5 (de) Verfahren zur herstellung substituierter, aliphatischer sekundaeramine
EP0192611A2 (de) Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
DE69015208T2 (de) Glutamin- und asparginsäurederivate mit antigastrinwirkung und verfahren zu deren herstellung.